Accuracy of mobile digital teledermoscopy for skin self-examinations in adults at high risk of skin cancer: an open-label, randomised controlled trial
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Skin self-examinations supplemented with mobile teledermoscopy might improve early detection of skin cancers compared with naked-eye skin self-examinations. We aimed to assess whether mobile teledermoscopy-enhanced skin self-examination can improve sensitivity and specificity of self-detection of skin cancers when compared with naked-eye skin self-examination. METHODS: This randomised, controlled trial was done in Brisbane (QLD, Australia). Eligible participants (aged ≥18 years) had at least two skin cancer risk factors as self-reported in the eligibility survey and had to own or have access to an iPhone compatible with a dermatoscope attachment (iPhone versions 5-8). Participants were randomly assigned (1:1), via a computer-generated randomisation procedure, to the intervention group (mobile dermoscopy-enhanced self-skin examination) or the control group (naked-eye skin self-examination). Control group and intervention group participants received web-based instructions on how to complete a whole body skin self-examination. All participants completed skin examinations at baseline, 1 month, and 2 months; intervention group participants submitted photographs of suspicious lesions to a dermatologist for telediagnosis after each skin examination and control group participants noted lesions on a body chart that was sent to the research team after each skin examination. All participants had an in-person whole-body clinical skin examination within 3 months of their last skin self-examination. Primary outcomes were sensitivity and specificity of skin self-examination, patient selection of clinically atypical lesions suspicious for melanoma or keratinocyte skin cancers (body sites examined, number of lesions photographed, types of lesions, and lesions missed), and diagnostic concordance of telediagnosis versus in-person whole-body clinical skin examination diagnosis. All primary outcomes were analysed in the modified intention-to-treat population, which included all patients who had a clinical skin examination within 3 months of their last skin self-examination. This trial was registered with the Australian and New Zealand Clinical Trials Registry, ACTRN12616000989448. FINDINGS: Between March 6, 2017, and June 7, 2018, 234 participants consented to enrol in the study, of whom 116 (50%) were assigned to the intervention group and 118 (50%) were assigned to the control group. 199 participants (98 participants in the intervention group and 101 participants in the control group) attended the clinical skin examination and thus were eligible for analyses. Participants in the intervention group submitted 615 lesions (median 6·0 per person; range 1-24) for telediagnosis and participants in the control group identified and recorded 673 lesions (median 6·0 per person; range 1-16). At the lesion level, sensitivity for lesions clinically suspicious for skin cancer was 75% (95% CI 63-84) in the intervention group and 88% (95% CI 80-91) in the control group (p=0·04). Specificity was 87% (95% CI 85-90) in the intervention group and 89% (95% CI 87-91) in the control group (p=0·42). At the individual level, the intervention group had a sensitivity of 87% (95% CI 76-99) compared with 97% (95% CI 91-100) in the control group (p=0·26), and a specificity of 95% (95% CI 90-100) compared with 96% (95% CI 91-100) in the control group. The overall diagnostic concordance between the telediagnosis and in-person clinical skin examination was 88%. INTERPRETATION: The use of mobile teledermoscopy did not increase sensitivity for the detection of skin cancers compared with naked-eye skin self-examination; thus, further evidence is necessary for inclusion of skin self-examination technology for public health benefit. FUNDING: National Health and Medical Research Council (Australia).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tschandl, P., Codella, N., Akay, B. N., Argenziano, G., Braun, R. P., Cabo, H., Gutman, D., Halpern, A., Helba, B., Hofmann-Wellenhof, R., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30333-x · Cited by 555
Self-citationChambers, D., Cantrell, A. J., Johnson, M., Preston, L., Baxter, S. K., Booth, A., & Turner, J. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-027743 · Cited by 218
Kroemer, S., Frühauf, J., Campbell, T. M., Massone, C., Schwantzer, G., Soyer, H. P., & Hofmann-Wellenhof, R. (2011) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2011.10208.x · Cited by 202
Self-citationUse of Smartphones for Early Detection of Melanoma: Systematic Review
Rat, C., Hild, S., Rault Sérandour, J., Gaultier, A., Quereux, G., Dreno, B., & Nguyen, J.-M. (2018) · Journal of Medical Internet Research · doi:10.2196/jmir.9392 · Cited by 105
A pilot trial of mobile, patient-performed teledermoscopy
Manahan, M. N., Soyer, H. P., Loescher, L. J., Horsham, C., Vagenas, D., Whiteman, D. C., Olsen, C. M., & Janda, M. (2015) · British Journal of Dermatology · doi:10.1111/bjd.13550 · Cited by 75
Self-citationWu, X., Oliveria, S. A., Yagerman, S., Chen, L., DeFazio, J., Braun, R., & Marghoob, A. A. (2015) · JAMA Dermatology · doi:10.1001/jamadermatol.2014.3837 · Cited by 67
Mobile teledermatology for skin cancer screening: A diagnostic accuracy study
Markun, S., Scherz, N., Rosemann, T., Tandjung, R., & Braun, R. P. (2017) · Medicine · doi:10.1097/md.0000000000006278 · Cited by 58
Enhanced Skin Self-examination: A Novel Approach to Skin Cancer Monitoring and Follow-up
Janda, M., Loescher, L. J., & Soyer, H. P. (2013) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.1218 · Cited by 50
Self-citationThe Remote Assessment of Melanocytic Skin Lesions: A Viable Alternative to Face-to-Face Consultation
Boyce, Z., Gilmore, S., Xu, C., & Soyer, H. P. (2011) · Dermatology · doi:10.1159/000333363 · Cited by 40
Self-citationJanda, M., Loescher, L. J., Banan, P., Horsham, C., & Soyer, H. P. (2014) · JAMA Dermatology · doi:10.1001/jamadermatol.2013.7743 · Cited by 38
Self-citation
Cited by
Human-computer collaboration for skin cancer recognition
Tschandl, P., Rinner, C., Apalla, Z., Argenziano, G., Codella, N., Halpern, A., Janda, M., Lallas, A., Longo, C., Malvehy, J., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0942-0 · Cited by 1,024
Self-citationThe role of technology in melanoma screening and diagnosis
Young, A. T., Vora, N. B., Cortez, J., Tam, A., Yeniay, Y., Afifi, L., Yan, D., Nosrati, A., Wong, A., Johal, A., et al. (2021) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12907 · Cited by 60
The clinical utility of teledermoscopy in the era of telemedicine
Uppal, S. K., Beer, J., Hadeler, E., Gitlow, H., & Nouri, K. (2021) · Dermatologic Therapy · doi:10.1111/dth.14766 · Cited by 39
“One potential reason for decreased detection of skin cancers may be due to lower rates of whole-body SSE with mobile teledermoscopy compared to FTF appointments.(5) Since fewer number of patients are referred to FTF appointments, there is an increased risk of so-called “unimaged melanomas,” lesions which are incidenta…”
BackgroundInfluentialReinders, P., Augustin, M., Kirsten, N., Fleyder, A., & Otten, M. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19392 · Cited by 19
“34,35 While there have been some studies on the effectiveness of S&F teledermatology for diagnostic purposes, 36,37 there is currently only one randomized controlled trial on the effectiveness of AI for image analysis in dermatology.”
BackgroundDiagnostic accuracy of teledermatology for skin diseases: a systematic review and meta-analysis
Martyin, K., Meznerics, F. A., Bokor, L. A., Szabó, B., Hegyi, P., Kiss, N., & Bánvölgyi, A. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1739592 · Cited by 4
Metadata
- Authors
- Janda, M., Horsham, C., Vagenas, D., Loescher, L. J., Gillespie, N., Koh, U., Curiel-Lewandrowski, C., Hofmann-Wellenhof, R., Halpern, A., Whiteman, D. C., Whitty, J. A., Smithers, B. M., & Soyer, H. P.
- Venue
- The Lancet Digital Health
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 2
- Issue
- 3
- Pages
- e129-e137
- ISSN
- 2589-7500 (ISSN-L)
- OpenAlex
- W3006694830
- Cited by
- 62
- References
- 10
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Accuracy of mobile digital teledermoscopy for skin self-examinations in adults at high risk of skin cancer: an open-label, randomised controlled trial. https://app.cochat.ai/papers/10.1016/s2589-7500(20)30001-7
- The paper
- Janda, M., Horsham, C., Vagenas, D., Loescher, L. J., Gillespie, N., Koh, U., Curiel-Lewandrowski, C., Hofmann-Wellenhof, R., Halpern, A., Whiteman, D. C., Whitty, J. A., Smithers, B. M., & Soyer, H. P. (2020). Accuracy of mobile digital teledermoscopy for skin self-examinations in adults at high risk of skin cancer: an open-label, randomised controlled trial. The Lancet Digital Health. https://doi.org/10.1016/s2589-7500(20)30001-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.